Skip to content

Invitation to presentation of the year-end report 2022

Oncopeptides AB (publ) a biotech company focused on the commercialization, research and development of therapies for difficult-to-treat hematological diseases, will publish the report for the fourth quarter and the 2022 year-end report, at 08:00 (CET) on February 16, 2023.

Investors, financial analysts, and media are invited to participate in a webcast and a following QnA session at 09:00 CET on the same day. The event will be hosted by Monica Shaw, CEO, together with Holger Lembrér, CFO, and the presentation will be held in English.

If you wish to participate via the webcast, please use the link below. Via the webcast you can ask written questions.

If you wish to participate via teleconference, please register on the link below. After the registration you will be provided a phone number and a conference ID to access the conference. You can ask questions verbally via the teleconference.

Source: Oncopeptides